Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma.
Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma. Leuk Res. 2013 Jul; 37(7):829-37.